The affinities of the monophosphates of 2'-fluoro-5-iodo-1-0-D-arabinofuranosyluracil and its 5smethyI analog for cellular thymidylate kinase were two or more orders of magnitude greater thap for the thymidine-thymidylate kinases from herpes simplex virus types 1 and 2. In contrpst, the monophosphate of (E)-5-(2-bromovinyl)-2'-deoxyuridine was found to have a higher affinity for the viral enzymes than for the cellular enzyme.
Several nucleoside analogs developed during the past few years (7, 9, 17, 20) show great promise for the chemotherapy of herpes simplex virus, varicella-zoster virus, cytomegalovirus, and Epstein-Barr virus infections. These antiherpes nucleoside analogs are preferential substrates for virally encoded thymidine-thymidylate kinase (1, 5) . They exert their antiviral activity after being phosphorylated to their triphosphate derivatives, which inhibit viral DNA synthesis by competing with natural substrates (10, 11, 18) . In some cases, the nucleoside analogs are also incorporated into viral DNA (10, 11, 13) . The initial phosphorylation to their monophosphate derivatives is produced by viral thymidinethymidylate kinase; however, the subsequent conversion to their diphosphate derivatives may depend upon either viral or host enzymes or both. The phosphorylation of acyclovir monophosphate to its diphosphate was shown to be a function of host cell guanylate kinase activity (15) , whereas (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVdUrd) monophosphate was preferentially phosphorylated by herpes simplex virus type 1 (HSV-1)-, herpes simplex virus type 2 (HSV-2)-, and varicella-zoster virus-encoded thymidine-thymidylate kinases (12) . The HSV-2 thymidine-thymidylate kinase only poorly phosphorylates BVdUrd monophosphate to its diphosphate, distinguishing it from the enzymes of HSV-1 and varicella-zoster virus (12) . The lower sensitivity of HSV-2 strains than of HSV-1 strains to BVdUrd inhibition was related to the lower levels of thymidylate kinase activity of the thymidine-thymidylate kinase found in HSV-2-infected cells. Although the rate of phosphorylation of BVdUrd monophosphate has been reported (12) , the affinity of BVdUrd monophosphate for cellular and viral enzymes has not been described. Thymidylate kinase from rapidly dividing Vero cells and thymidine-thymidylate kinases from LMTK-cells infected with HSV-1 (KOS strain) and HSV-2 (MS strain) were purified as described by Cheng and Ostrander (6) and Chen and Prusoff (3). Enzymes were changed to the ATP. MG2' form before being used in kinetic studies by passage through a Sephadex G-25-40 column (Sigma Chemical Co., St. Louis, Mo.) equilibrated with 1 mM ATP. Mg2+-10 mM Tris (pH 7.5)-10% glycerol and were eluted with the same buffer. The assay for enzyme activities and analysis of kinetic data were done as described previously (2, 4) .
The kinetic constants of the monophosphates of the nucleoside analogs for thymidylate kinase from Vero cells and thymidine-thymidylate kinases from HSV-1 and HSV-2 are shown in Table 1 . Thymidylate kinase from Vero cells showed a higher affinity for its normal substrate, thymidylate, than did the viral enzymes. The Km of thymidylate for the HSV-2-encoded thymidine-thymidylate kinase was ca. cellular enzyme, and the HSV-1 enzyme had the highest affinity for BVdUrd monophosphate of the three enzymes studied. BVdUrd has been reported to be about 100-fold less active against HSV-2 than against HSV-1 (8), and this is consistent with the levels of thymidylate kinase activity of the virus-encoded thymidine-thymidylate kinase found in HSV-2 being 50-fold lower than those in HSV-1 (12) . In addition, the HSV-2 thymidylate kinase also had a lower affinity for BVdUrd monophosphate than did the HSV-1 enzyme, and cellular thymidylate kinase had a poor affinity for BVdUrd monophosphate. The combination of these factors results in the relative resistance of HSV-2 to BVdUrd as compared with the resistance of HSV-1 to BVdUrd. The monophosphate of IdUrd showed a similar affinity for both the cellular and the viral enzymes. Thus, at the level of thymidylate kinase, IdUrd monophosphate has no selectivity for herpes simplex virus, and this may be reflected in the toxicity associated with this drug. Although previous studies have indicated that FIAC has antiviral activity in cell cultures and animals (14, 16, 19) , the presence of FIAC triphosphate has not been reported in either in vitro or in vivo systems (13) . However, metabolites of FIAC (principally 2'-fluoro-5-iodo-1-1-D-arabinofuranosyluracil) have been shown to be incorporated into cellular and viral DNAs (13) . All of the three enzymes tested in our study had a low affinity for FIAC monophosphate. These findings would suggest that either FIAC monophosphate is acted on by enzymes other than the thymidine-thymidylate kinases studied here or that the antiviral activity of FIAC is dependent upon its deamination to 2'-fluoro-5-iodo-1-3-Darabinofuranosyluracil at either the nucleoside or the monophosphate level. The observation that FIAC had no inhibitory activity against Marek's disease virus in chicken embryo fibroblasts lacking 2'-deoxycytidine deaminase, whereas the virus was inhibited by FIAC in chicken kidney cells containing the enzyme, may support the latter hypothesis (K. A. Schat, Antiviral Res., in press).
